118 related articles for article (PubMed ID: 7954353)
1. Somatostatin analogue octreotide modulates metabolism and effects of 5-fluorouracil and 5-fluorouridine in human colon cancer spheroids.
Chen TB; Huzak M; Macura S; Vuk-Pavlović S
Cancer Lett; 1994 Oct; 86(1):41-51. PubMed ID: 7954353
[TBL] [Abstract][Full Text] [Related]
2. Differences in metabolism of 5-fluorouracil and 5-fluorouridine and regulation by glucosamine in human colon cancer multicell tumor spheroids.
Chen TB; Bajzer Z; Macura S; Vuk-Pavlovic S
NMR Biomed; 1999 May; 12(3):157-67. PubMed ID: 10414950
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis of 5-fluorouracil action against various cancer cells.
Inaba M; Mitsuhashi J; Ozawa S
Jpn J Cancer Res; 1990 Oct; 81(10):1039-44. PubMed ID: 2146239
[TBL] [Abstract][Full Text] [Related]
4. On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice.
Houghton JA; Houghton PJ
Cancer; 1980 Mar; 45(5 Suppl):1159-67. PubMed ID: 6444543
[TBL] [Abstract][Full Text] [Related]
5. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
Glazer RI; Lloyd LS
Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.
Zhao B; Zhao H; Zhao N; Zhu XG
J Hepatobiliary Pancreat Surg; 2002; 9(4):497-502. PubMed ID: 12483273
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin-14 and its analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block.
Cheung NW; Boyages SC
Endocrinology; 1995 Oct; 136(10):4174-81. PubMed ID: 7664634
[TBL] [Abstract][Full Text] [Related]
8. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.
Matsui SI; Arredondo MA; Wrzosek C; Rustum YM
Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989
[TBL] [Abstract][Full Text] [Related]
9. 19F nuclear magnetic resonance study of fluoropyrimidine metabolism in strains of Candida glabrata with specific defects in pyrimidine metabolism.
Fasoli MO; Kerridge D; Morris PG; Torosantucci A
Antimicrob Agents Chemother; 1990 Oct; 34(10):1996-2006. PubMed ID: 2291666
[TBL] [Abstract][Full Text] [Related]
10. [Effect of somatostatin analog SMS 201-995 on the growth in vitro and in vivo of colonic adenocarcinoma CT 26 in mice].
Alonso M; Galera MJ; Reyes G; Viñals A; Rosell E; Rius X
Gastroenterol Clin Biol; 1992; 16(1):12-5. PubMed ID: 1537476
[TBL] [Abstract][Full Text] [Related]
11. Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil.
Pizzorno G; Sun Z; Handschumacher RE
Biochem Pharmacol; 1995 Feb; 49(4):553-7. PubMed ID: 7872961
[TBL] [Abstract][Full Text] [Related]
12. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
Takimoto CH; Cadman EC; Armstrong RD
Mol Pharmacol; 1986 Jun; 29(6):637-42. PubMed ID: 2940459
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.
Iigo M; Nishikata K; Nakajima Y; Szinai I; Veres Z; Szabolcs A; De Clercq E
Biochem Pharmacol; 1990 Apr; 39(7):1247-53. PubMed ID: 2138895
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive fluorine-19 NMR study of fluoropyrimidine metabolism in cell cultures of human pancreatic and colon adenocarcinoma.
Malet-Martino MC; Faure F; Vialaneix JP; Palevody C; Hollande E; Martino R
Cancer Chemother Pharmacol; 1986; 18(1):5-10. PubMed ID: 2944669
[TBL] [Abstract][Full Text] [Related]
16. Octreotide (SMS 201-995) inhibits the growth of colon peritoneal carcinomatosis in BDIX rats.
Ruszniewski P; Lehy T; Reyl-Desmars F; Le Roux S; Lewin MJ
Regul Pept; 1993 Feb; 43(3):141-7. PubMed ID: 8441819
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells.
Keniry M; Benz C; Shafer RH; James TL
Cancer Res; 1986 Apr; 46(4 Pt 1):1754-8. PubMed ID: 3456267
[TBL] [Abstract][Full Text] [Related]
18. SMS 201.995 (Sandostatin) enhances in-vitro effects of 5-fluorouracil in colorectal cancer.
Romani R; Morris DL
Eur J Surg Oncol; 1995 Feb; 21(1):27-32. PubMed ID: 7851548
[TBL] [Abstract][Full Text] [Related]
19. Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells.
Sharma K; Srikant CB
Int J Cancer; 1998 Apr; 76(2):259-66. PubMed ID: 9537589
[TBL] [Abstract][Full Text] [Related]
20. Assignment and pH dependence of the 19F-NMR resonances from the fluorouracil anabolites involved in fluoropyrimidine chemotherapy.
Lutz NW; Hull WE
NMR Biomed; 1999 Jun; 12(4):237-48. PubMed ID: 10421915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
